NEVVI Medicare utilization intelligence

← back

GRECO, AUSTINM.D. NPI 1033645486 Clinician

Hematology-Oncology · AMES, IA

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF IOWA, RJ & L CARVER COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 9 years since medical school (class of 2017, self-reported to CMS)
Location AMES, IA · NPPES registered location
Active in data Billed Medicare 2023–2024 (2 consecutive years)
Scale 70 codes billed · 121,544 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20242026
MCFARLAND CLINIC PC
2024–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2023-07

Year: 2024 · 2023

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
J9267 Injection, paclitaxel, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
J2469 Injection, palonosetron hcl, 25 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J0897 Injection, denosumab, 1 mg
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
83735 Magnesium level
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J3475 Injection, magnesium sulfate, per 500 mg
J9045 Injection, carboplatin, 50 mg
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96372 Injection of drug or substance under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
84443 Blood test, thyroid stimulating hormone (tsh)
84439 Thyroxine (thyroid chemical), free
82607 Cyanocobalamin (vitamin b-12) level
96375 Injection of additional new drug or substance into vein
82746 Folic acid level, serum
83615 Lactate dehydrogenase (enzyme) level
96415 Administration of chemotherapy into vein, each additional hour
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96417 Administration of additional new drug or substance into vein, 1 hour or less
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
84165 Protein measurement, serum
86334 Immunologic analysis technique on serum (immunofixation)
85045 Red blood count, automated test
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
J1200 Injection, diphenhydramine hcl, up to 50 mg
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J3490 Unclassified drugs
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
85007 Microscopic examination for white blood cells with manual cell count
J7030 Infusion, normal saline solution , 1000 cc
96360 Infusion into a vein for hydration, 31-60 minutes
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96411 Administration of additional new drug or substance into vein using push technique
99238 Hospital discharge day management, 30 minutes or less
90662 Influenza vaccine split virus, preservative free
G0008 Administration of influenza virus vaccine
82378 Carcinoembryonic antigen (cea) protein level
86803 Hepatitis c antibody measurement
96523 Irrigation of implanted venous access drug delivery device
86880 Red blood cell antibody detection test, direct
87340 Detection test by immunoassay technique for hepatitis b surface antigen
86706 Hepatitis b surface antibody measurement
38222 Biopsy and aspiration of bone marrow sample for diagnosis
84550 Uric acid level, blood
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
84100 Phosphate level
99239 Hospital discharge day management, more than 30 minutes
86703 Analysis for antibody to hiv-1 and hiv-2 virus
84155 Total protein level, blood

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.